BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Prognosis
27 results:

  • 1. Development and validation of an individualized angiogenesis and tumor-infiltrating lymphocytes prognostic signature in nasopharyngeal carcinoma.
    Zhang R; Liao X; Zhang B; Huang X; Qin G; Kong X; Xie Y; Mo Y; Dai J; Gan C; Luo Z; Lu J; Jiang W
    Pathol Res Pract; 2024 Jan; 253():154936. PubMed ID: 38006840
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Vision Transformer-Based Multilabel Survival Prediction for Oropharynx cancer After Radiation Therapy.
    Chen M; Wang K; Wang J
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):1123-1134. PubMed ID: 37939732
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Development and validation of a nomogram for predicting the early death of anaplastic thyroid cancer: a SEER population-based study.
    Cui H; Wang R; Zhao X; Wang S; Shi X; Sang J
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16001-16013. PubMed ID: 37689588
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cuproptosis-related risk score based on machine learning algorithm predicts prognosis and characterizes tumor microenvironment in head and neck squamous carcinomas.
    Ye M; Zhang G; Lu Y; Ren S; Ji Y
    Sci Rep; 2023 Jul; 13(1):11870. PubMed ID: 37481622
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic Model and Nomogram for Early-Onset Adenoid Cystic Carcinoma of head and neck: A Retrospective SEER-Based Analysis.
    Dai L; Zhang SZ; Wu YH
    Technol Cancer Res Treat; 2023; 22():15330338231163026. PubMed ID: 37078162
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma.
    Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y
    Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A visualized dynamic prediction model for survival of patients with geriatric thyroid cancer: A population-based study.
    Zhang TT; Zeng J; Yang Y; Wang JJ; Kang YJ; Zhang DH; Liu XZ; Chen K; Wang X; Fang Y
    Front Endocrinol (Lausanne); 2022; 13():1038041. PubMed ID: 36568078
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A novel prognostic model for papillary thyroid cancer based on epithelial-mesenchymal transition-related genes.
    Liu R; Cao Z; Pan M; Wu M; Li X; Yuan H; Liu Z
    Cancer Med; 2022 Dec; 11(23):4703-4720. PubMed ID: 35608185
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic Relevance of Weight and Weight Loss during Multimodal Therapy for Oesophagogastric Tumours.
    Lorusso A; Bichev D; Högner A; Bartels P; Ballhausen A; Treese C; Biebl M; Thuss-Patience P
    Curr Oncol; 2022 Apr; 29(4):2706-2719. PubMed ID: 35448195
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
    Wang T; Tian K; Ji X; Song F
    Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Immunohistochemical detection of "ex novo" HLA-DR in tumor cells determines clinical outcome in laryngeal cancer patients.
    Prampolini C; Almadori G; Bonvissuto D; Barba M; Giraldi L; Boccia S; Paludetti G; Galli J; Parolini O; Settimi S; Cadoni G
    HLA; 2021 Dec; 98(6):517-524. PubMed ID: 34605215
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nomograms for Differentiated Thyroid Carcinoma Patients Based on the Eighth AJCC Staging and Competing Risks Model.
    Li C; Xu F; Huang Q; Han D; Zheng S; Wu W; Zhao F; Feng X; Lyu J
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34159295
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Nomogram for predicting the survival of patients with small cell carcinoma of the esophagus: A population study based on the surveillance, epidemiology, and end results database.
    Qie S; Wang XF; Ran YG; Liu ML; Cui GM; Shi HY
    Medicine (Baltimore); 2021 Apr; 100(15):e25427. PubMed ID: 33847642
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. What has the National cancer Database taught us about oral cavity squamous cell carcinoma?
    Graillon N; Iocca O; Carey RM; Benjamin K; Cannady SB; Hartner L; Newman JG; Rajasekaran K; Brant JA; Shanti RM
    Int J Oral Maxillofac Surg; 2022 Jan; 51(1):10-17. PubMed ID: 33840565
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Detection of human papillomavirus infection in laryngeal and hypopharyngeal carcinoma using droplet digital PCR and its correlation with prognosis.
    Chen L; Dong P; Yu Z
    Postgrad Med; 2021 Aug; 133(6):619-625. PubMed ID: 33754942
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Prognostic Predictive System Based on Deep Learning for Locoregionally Advanced Nasopharyngeal Carcinoma.
    Qiang M; Li C; Sun Y; Sun Y; Ke L; Xie C; Zhang T; Zou Y; Qiu W; Gao M; Li Y; Li X; Zhan Z; Liu K; Chen X; Liang C; Chen Q; Mai H; Xie G; Guo X; Lv X
    J Natl Cancer Inst; 2021 May; 113(5):606-615. PubMed ID: 32970812
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Insurance Status as a Predictor of Treatment in Human Papillomavirus Positive Oropharyngeal cancer.
    Berger MH; Yasaka TM; Haidar YM; Kuan EC; Tjoa T
    Laryngoscope; 2021 Apr; 131(4):776-781. PubMed ID: 32790156
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
    Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High/positive expression of ERCC1 predicts poor treatment response and survival prognosis in nasopharyngeal carcinoma: A systematic meta-analysis from 21 studies.
    Yang L; Wei W; Zhou L; Wang J; Hu G
    Medicine (Baltimore); 2019 May; 98(21):e15641. PubMed ID: 31124943
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
    Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.